Immunization, Vaccines and Biologicals

Research and development

WHO’s Initiative for Vaccine Research (IVR) facilitates vaccine research and development (R&D) against pathogens with significant disease and economic burden, with a particular focus on low and middle income countries. Our activities span the following areas:

  • facilitation of early stage R&D in disease areas with no available vaccines or sub-optimal vaccines,
  • research to optimize public health impact where existing vaccines are underutilized,
  • research to aid introduction decision-making and post-licensure assessments of risk/benefit
  • research to improve monitoring and evaluation of vaccines in use in immunization programmes.

IVR activities align with the strategic objective 6 of the Global Vaccine Action Plan “Country, regional and global research and development innovations maximize the benefits of immunization”, and with the fifth goal of the Decade of Vaccines “Develop and introduce new and improved vaccines and technologies”.

Vaccine research areas of work

Initiatives and forums

Global Vaccine and Immunization Research Forum

The Forum brings together researchers, public health professionals and other key stakeholders to discuss progress and challenges in vaccine development and implementation research as identified in the Global Vaccine Action Plan.

Meningitis Vaccine Project

The Meningitis Vaccine Project (MVP) was a partnership of the World Health Organization (WHO) and PATH, June 2001-December 2014.

WHO-UNAIDS HIV Vaccine Initiative

The WHO-UNAIDS HIV Vaccine Initiative is a joint activity of the World Health Organization (WHO) and the Joint United Nations Programme on HIV/AIDS (UNAIDS).

Meetings, workshops and events

Action against meningitis

Technical task force on meningitis

The Technical Taskforce for the development of a "roadmap to defeat meningitis by 2030" has held its first meeting in July 2018.

A group of African girls laughing

DEFEATING MENINGITIS BY 2030: baseline situation analysis

The baseline situation analysis (BSA) is intended to inform the development of the global roadmap Defeating meningitis by 2030 and to provide a sound basis to inform its key priorities.

Contact us

Initiative for Vaccine Research
Immunization, Vaccines and Biologicals
World Health Organization (WHO)
20 Avenue Appia
1211 Geneva 27
Fax: +41 (22) 791 48 60

For information on vaccination requirements for international travellers, please visit the WHO international travelers pages